GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
galena biopharma (GALE) [hlAlert]

Rating:
Outperform
GALE
down 61.59 %

galena biopharma (GALE) rated Outperform with price target $4 by Oppenheimer

Posted on: Thursday,  Nov 12, 2015  9:25 AM ET by Oppenheimer

Oppenheimer rated Outperform galena biopharma (NASDAQ: GALE) on 11/12/2015. Previously Oppenheimer rated Outperform galena biopharma (NASDAQ: GALE) on 11/26/2013., when
the stock price was $3.88. Since then, galena biopharma has lost 61.60% as of 01/21/2016's recent price of $1.49.
If you would have followed the previous Oppenheimer's recommendation on GALE, you would have lost 61.59% of your investment in 786 days.

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other therapeutic areas with potential partners. RXi commenced operations after CytRx Corporation contributed to the Company its portfolio of RNAi therapeutic assets, which consisted primarily of RNAi licenses and related intellectual property, and a nominal amount of equipment. As of December 31, 2008, the Company had not generated any revenues.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2015 9:25 AM Buy
None
1.48 4.00
as of 8/27/2015
1 Week down  -1.32 %
1 Month down  -23.19 %
3 Months up  9.55 %
1 YTD down  -69.95 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/26/2013 8:25 AM Buy
None
3.88 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy